AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX
We are building an AI-native operating system for pharma sales and distribution
We are building an AI-native operating system for pharma sales and distribution
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Expands bioprocessing footprint across Asia
The State’s PPP model has already mobilised Rs. 150 crore in core infrastructure, while Thermo Fisher has invested Rs. 90 crore in the Bioprocess Design Centre and its co-located Customer Experience Centre
The move is expected to be crucial during health crises
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Subscribe To Our Newsletter & Stay Updated